Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹41Cr
Fertilizers - Phosphatic - Single Super Phosphate
Rev Gr TTM
Revenue Growth TTM
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

BOHRAIND
VS
| Quarter | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | | | | | | | | | | | | |
| 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 2 | 0 | 0 | 0 |
Operating Profit Operating ProfitCr |
| | | | | | | | | | | | |
Other Income Other IncomeCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Interest Expense Interest ExpenseCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation DepreciationCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| -1 | -1 | -1 | -1 | -1 | -1 | -1 | 0 | -2 | -1 | -1 | -1 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|
Growth YoY PAT Growth YoY% | -32.1 | 21.5 | 0.0 | 25.9 | -32.4 | 6.5 | -21.4 | 31.8 | -102.0 | -19.0 | 5.9 | -39.5 |
| | | | | | | | | | | | |
| -0.5 | -0.4 | -0.4 | -0.4 | -0.7 | -0.4 | -0.5 | -0.3 | -1.4 | -0.3 | -0.3 | -0.3 |
| Financial Year | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|
|
| | -9.9 | 23.6 | -24.2 | -99.5 | -100.0 | | | | | |
| 98 | 87 | 107 | 125 | 46 | 1 | 1 | 2 | 1 | 3 | 3 |
Operating Profit Operating ProfitCr |
| 12.7 | 14.1 | 14.4 | -31.2 | -10,050.6 | | | | | | |
Other Income Other IncomeCr | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Interest Expense Interest ExpenseCr | 8 | 8 | 9 | 9 | 5 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation DepreciationCr | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 |
| 6 | 6 | 9 | -40 | -52 | -3 | -3 | -3 | -3 | -4 | -4 |
| 1 | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|
| | -12.4 | 87.4 | -643.9 | -28.7 | 94.7 | 4.6 | -12.2 | 12.3 | -42.9 | -6.2 |
| 4.0 | 3.9 | 5.9 | -42.4 | -11,381.4 | | | | | | |
| 5.0 | 2.6 | 4.9 | -26.4 | -34.0 | -1.8 | -2.5 | -2.1 | -1.8 | -2.6 | -2.3 |
| Financial Year | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|
Equity Capital Equity CapitalCr | 9 | 15 | 15 | 15 | 15 | 15 | 10 | 10 | 14 | 14 | 21 |
| 30 | 60 | 65 | 25 | -27 | -30 | 34 | 45 | 43 | 39 | 53 |
Current Liabilities Current LiabilitiesCr | 65 | 71 | 76 | 82 | 80 | 81 | 17 | 2 | 3 | 5 | 5 |
Non Current Liabilities Non Current LiabilitiesCr | 17 | 14 | 19 | 21 | 26 | 26 | 3 | 1 | 1 | 1 | 1 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 97 | 134 | 134 | 104 | 58 | 57 | 37 | 37 | 37 | 36 | 59 |
Non Current Assets Non Current AssetsCr | 23 | 27 | 42 | 39 | 37 | 35 | 27 | 26 | 24 | 23 | 22 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | 5 | 2 | -2 | -6 | -9 | -1 | 16 | -2 | 0 | 0 |
Investing Cash Flow Investing Cash FlowCr | -1 | -5 | -17 | -2 | 1 | 0 | 1 | 0 | 0 | 0 |
Financing Cash Flow Financing Cash FlowCr | -3 | 28 | -5 | 5 | 7 | 0 | -18 | 2 | 0 | 0 |
|
Free Cash Flow Free Cash FlowCr | 3 | 2 | -13 | -8 | -9 | -1 | 18 | -2 | 0 | 0 |
| 101.3 | 41.7 | -23.2 | 14.2 | 18.1 | 41.5 | -629.2 | 70.3 | 2.9 | 11.9 |
CFO To EBITDA CFO To EBITDA% | 32.0 | 11.5 | -9.6 | 19.2 | 20.4 | 78.4 | -1,201.9 | 117.8 | 5.2 | 17.1 |
| Financial Year | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 0 | 0 | 49 | 18 | 1 | 3 | 0 | 109 | 27 | 53 |
Price To Earnings Price To Earnings | 0.0 | 0.0 | 6.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Price To Sales Price To Sales | 0.0 | 0.0 | 0.4 | 0.2 | 1.8 | | | | | |
Price To Book Price To Book | 0.0 | 0.0 | 0.6 | 0.4 | -0.1 | -0.2 | 0.0 | 1.4 | 0.5 | 1.0 |
| 3.8 | 2.3 | 6.1 | -3.1 | -2.1 | -67.3 | -11.7 | -62.2 | -19.3 | -21.0 |
Profitability Ratios Profitability Ratios |
| 36.4 | 32.0 | 33.2 | -8.8 | -6,421.2 | | | | | |
| 12.7 | 14.1 | 14.4 | -31.2 | -10,050.6 | | | | | |
| 4.0 | 3.9 | 5.9 | -42.4 | -11,381.4 | | | | | |
| 14.0 | 9.9 | 12.1 | -26.0 | -56.5 | -3.6 | -4.6 | -5.6 | -4.8 | -7.2 |
| 11.7 | 5.3 | 9.2 | -100.8 | 436.7 | 18.8 | -5.9 | -5.3 | -4.5 | -6.9 |
| 3.8 | 2.5 | 4.2 | -28.2 | -55.1 | -3.0 | -4.1 | -4.7 | -4.2 | -6.2 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
Bohra Industries Limited is an Indian fertilizer manufacturer currently undergoing a comprehensive structural and strategic transformation. Originally incorporated in **1996**, the company is transitioning from a period of insolvency-induced dormancy toward a revitalized operational phase under new global ownership. Following a **Corporate Insolvency Resolution Process (CIRP)** approved by the **NCLT** on **October 13, 2021**, the company is now executing a "Change in Control" strategy to resume its position in the essential agricultural nutrients market.
---
### **Strategic Ownership Transition & Management Reconstitution**
The company is currently the subject of a significant takeover and recapitalization effort led by **Mark AB Capital Private Limited** (formerly Mark AB Capital Investment India Private Limited).
* **Change in Control:** In **August 2025**, a change in control was initiated following an **Open Offer** by the Acquirer. This resulted in the reclassification of the former promoters to the public category.
* **Acquirer Stake:** Under a **Share Subscription Agreement (SSA)**, the Acquirer was allotted **68,75,000 equity shares** (representing **29.64%** of the emerging voting capital) at **₹32 per share**.
* **Mandatory Open Offer:** An offer was launched to acquire up to **70,19,667 equity shares** (**30.26%** of voting capital) from public shareholders at **₹32 per share**, totaling **₹22.46 Crore**.
* **New Leadership:** **Mr. Atul Dave** has been appointed as **Managing Director** for a **5-year term** effective **September 7, 2025**. The board has been further strengthened with the appointment of several Non-Executive Directors to enhance corporate governance.
* **Administrative Shift:** To exploit new business opportunities and improve oversight, the Board approved shifting the **Registered Office** from **Udaipur, Rajasthan** to the **National Capital Territory (NCT) of Delhi**.
---
### **Capital Structure & Listing Status**
The company migrated from the **NSE EMERGE** platform to the **NSE Main Board** on **October 27, 2022**, signaling its intent to engage with a broader investor base.
| Metric | Details (as of mid-2025) |
| :--- | :--- |
| **NSE Symbol / ISIN** | **BOHRAIND** / **INE802W01023** |
| **Authorized Share Capital** | **₹ 30,00,00,000** |
| **Paid-up Equity Capital** | **₹ 21,17,21,520** |
| **Dematerialization** | **100%** (Held via NSDL and CDSL) |
| **Public Shareholding** | Minimum **25%** required (SEBI/SCRR compliance) |
**Recent Capital Raising Activities:**
The company has utilized preferential allotments of equity and convertible warrants to fund its turnaround:
* **June 2025:** Raised **₹22.00 Crore** via equity and **₹6.48 Crore** via **20,25,002** warrants at **₹32**.
* **October 2025:** Issued **40,00,000** warrants at **₹31**, totaling **₹12.40 Crore**.
* **Warrant Terms:** Convertible **1:1** within **18 months**; **25%** upfront payment with **75%** due upon exercise.
---
### **Product Portfolio & Market Positioning**
Bohra Industries operates in a **single business segment: Fertilizer products**. The company focuses on soil enrichment through synthetic compounds designed to enhance crop yields.
* **Core Manufacturing:** Production of **Single Super Phosphate (SSP)** and **Granulated Single Super Phosphate (GSSP)** in both powder and granulated forms.
* **Premium Fortification:** A strategic foray into **Zincated SSP**, integrating **Zinc** as a micronutrient to improve soil quality and crop resistance.
* **Trading Operations:** Sourcing and distribution of **Rock Phosphate**, **NPK Compounds** (Nitrogen, Phosphorous, Potassium), and other secondary nutrients based on market demand.
* **Quality Standards:** The facility is **ISO 9001:2008**, **ISO 14001:2004**, and **OHSAS 18001:2007** certified, featuring an in-house laboratory compliant with the **Fertilizer Control Order (FCO)**.
---
### **Operational Infrastructure & Asset Base**
While the company is currently in a non-operational state, it maintains a significant physical and technical foundation for a restart.
* **Manufacturing Plant:** Located in **Udaipur, Rajasthan**.
* **Automation:** The facility is historically noted as being fully automated and **PLC controlled**.
* **Asset Valuation:** As of **March 31, 2025**, the company reported **Non-Current Assets** of **₹22.70 Crores**, including **₹15.82 Crores** in Fixed Assets (Property, Plant, and Equipment).
* **Inventory Management:** A phased verification program for PPE is conducted every **three years**. No new manufacturing activity or purchases were recorded in **FY 2023-24**.
---
### **Financial Performance & Recovery Status**
The company’s financials reflect a "pre-revenue" recovery phase following the insolvency process.
| Metric (Standalone) | FY 2024-25 (₹ in Crore) | FY 2023-24 (₹ in Crore) |
| :--- | :---: | :---: |
| **Total Revenue** | **0.00** | **0.00** |
| **Net Profit / (Loss)** | **(3.68)** | **(2.58)** |
| **Depreciation** | **1.35** | **1.36** |
| **Trade Receivables** | **29.45** | **-** |
**Debt Restructuring:**
Following the NCLT resolution, liabilities have been restructured to **₹1.20 Crores** (Long Term) and **₹4.69 Crores** (Current). An escrow account with **ICICI Bank** holds **₹5.61 Crore** (25% of the Open Offer consideration) to secure the acquisition process.
---
### **Critical Risk Factors & Challenges**
#### **1. Operational & Liquidity Constraints**
* **Stalled Activity:** The company has reported **NIL turnover** for three consecutive years. Future viability depends entirely on the successful deployment of new capital to restart the Udaipur plant.
* **NOC Delays:** A major bottleneck was resolved on **April 24, 2024**, when the **NCLAT** ordered a financial creditor to release a mandatory **No Objection Certificate (NOC)**, which had previously blocked access to bank credit facilities.
#### **2. Regulatory & Compliance History**
* **Trading Suspension:** Trading on the **NSE** was suspended from **August 16, 2024**, to **March 03, 2025**, due to non-compliance with **SEBI (LODR)** regulations.
* **Governance Gaps:** Past failures include delayed financial filings, lack of a **CFO** in **FY 2023-24**, and failure to maintain records in **Structured Digital Database (SDD)** software per insider trading norms.
#### **3. Macro-Economic & Industry Risks**
* **Subsidy Dependency:** Revenue is heavily tied to **Government of India** subsidies. Any shift in agricultural policy or delay in subsidy disbursement impacts cash flow.
* **Input Volatility:** The business is sensitive to the fluctuating prices of **Rock Phosphate** and global energy costs.
* **Environmental Norms:** Operations must adhere to stringent quality and marking guidelines set by the **Fertilizer Association of India**.
---
### **Future Outlook & Growth Drivers**
The management’s strategy for revival is anchored in three pillars:
1. **National Alignment:** Leveraging government initiatives aimed at **doubling farmer income** to drive demand for synthetic fertilizers.
2. **Capital Utilization:** Proceeds from recent warrant and equity issues are earmarked for **working capital**, **debt repayment**, and potential **subsidiary investments**.
3. **Modernization:** Transitioning from traditional farming substances to high-yield **modern synthetic compounds** and fortified nutrients like **Zincated SSP** to capture higher margins.